HomeMarket NewsSNPHY Stock Earnings: Santen Pharmaceutical Reported Results for Q4 2023

SNPHY Stock Earnings: Santen Pharmaceutical Reported Results for Q4 2023

Actionable Trade Ideas

always free

SNPHY stock - SNPHY Stock Earnings: Santen Pharmaceutical Reported Results for Q4 2023

Source: iQoncept / Shutterstock

Santen Pharmaceutical (OTCMKTS:SNPHY) just reported results for the fourth quarter of 2023.

  • Santen Pharmaceutical reported earnings per share of 16 cents.
  • The company reported revenue of $533.27 million.

InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com.


Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/05/snphy-stock-earnings-santen-pharmaceutical-for-q4-of-2023/.

©2024 InvestorPlace Media, LLC

Swing Trading Ideas and Market Commentary

Need some new swing ideas? Get free weekly swing ideas and market commentary from Jonathan Bernstein here: Swing Trading.

Explore More

Weekly In-Depth Market Analysis and Actionable Trade Ideas

Get institutional-level analysis and trade ideas to take your trading to the next level, sign up for free and become apart of the community.